FdaApplication
ANDA 217565
Identifiers
- fda_app_no: ANDA217565
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMOBEDIENT CONSULTING LLC |
| application_type | ANDA |
| approval_date | 2024-10-31 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EDARAVONE | EDARAVONE | 60MG/100ML (0.6MG/ML) | SOLUTION;INTRAVENOUS |
| EDARAVONE | EDARAVONE | 30MG/100ML (0.3MG/ML) | SOLUTION;INTRAVENOUS |
2 products